An in-depth guide from the team at Paradise Medical Center Primary Care in Miami, FL.
Call (305) 676-8217Obesity and metabolic syndrome are now recognized as treatable medical diseases — not personal failings. Modern obesity medicine combines proven behavioral coaching with prescription therapies that finally make sustained weight loss achievable for the majority of patients.
Here's how we approach clinical fat loss as a comprehensive primary care service.
Metabolic syndrome is diagnosed when 3 or more of the following are present:
Central obesity: Waist circumference >40 inches (men), >35 inches (women)
High triglycerides: ≥150 mg/dL
Low HDL cholesterol: <40 (men), <50 (women)
High blood pressure: ≥130/85 or on medication
Elevated fasting glucose: ≥100 mg/dL
Metabolic syndrome dramatically raises risk of type 2 diabetes (5x), cardiovascular disease (2x), and stroke. The underlying driver is insulin resistance — and good news: it often improves substantially with even modest weight loss.
More than 40% of U.S. adults have obesity, and millions more have metabolic syndrome. Standard 'eat less, move more' advice helps fewer than 1 in 10 patients achieve sustained results — because biology actively resists weight loss through hormone changes, slowed metabolism, and increased hunger.
Modern clinical care addresses the biology, not just the behavior. The CDC tracks rising obesity prevalence and emphasizes the need for medical management.
Every patient starts with a thorough evaluation:
Body composition: BMI, waist circumference, body composition analysis
Metabolic labs: Lipid panel, HbA1c, fasting insulin (HOMA-IR), liver function
Hormonal labs: Thyroid panel, vitamin D, B12, testosterone (men)
Cardiovascular assessment: Blood pressure trends, EKG when indicated
Through our in-office lab services.
FDA-approved GLP-1 receptor agonists produce 15–22% body weight loss over 12–18 months — comparable to bariatric surgery without the surgery:
Wegovy (semaglutide): ~15% weight loss
Zepbound (tirzepatide): ~20% weight loss
Ozempic, Mounjaro: Same medications used for diabetes, often easier to obtain insurance coverage
We handle prior authorization, dose titration, and side effect management. See our medical weight loss guide.
Mediterranean-style or low-carb eating plans tailored to your culture and preferences. Bilingual coaching in English and Spanish. We focus on:
Practical, sustainable changes — not extreme dieting
Meal planning and grocery strategies
Resistance training to preserve lean mass
Sleep optimization (critical for weight loss)
Behavioral patterns and emotional eating
Metabolic syndrome is fundamentally a cardiovascular disease. Joint management of:
Lifestyle factors (sleep apnea, fatty liver disease)
Obesity, like hypertension or diabetes, is a chronic disease requiring lifelong management. Through our chronic care management program, monthly check-ins maintain dose and prevent regain after initial weight loss.
Stopping medication generally results in gradual weight regain — long-term treatment is the standard of care.
Many patients on GLP-1 therapy benefit from B12 injections to maintain energy during caloric reduction and metabolic shift.
Ready to learn more? Visit our dedicated service page or call (305) 676-8217 to schedule a consultation.
Metabolic syndrome includes obesity plus other markers (high BP, lipids, glucose). Both are linked but distinct.
Yes — strong long-term safety data. Side effects are usually mild GI symptoms.
On modern medications + lifestyle: 15–22% over 12–18 months. Lifestyle alone typically yields 5–10%.
Diabetes-indicated GLP-1s are widely covered. Pure weight-loss approval varies — we help navigate prior authorization.
Most patients regain weight without ongoing treatment. Long-term maintenance is part of the plan.
Speak with our medical team about a personalized plan.
Call (305) 676-8217